ghk cu pepride 89030-95-5 GHK-Cu Gly-His-Lys-Cu Copper Tripeptide-1; Prezatide copper GHK-Cu (Copper Peptide) Deep Dive:

Research Applications Summary BPC-157: primary choice for gastrointestinal, tendon, and NO-pathway research TB-500: primary choice for actin biology, cellular migration, cardiac, and dermal wound research Both: angiogenesis and anti-inflammatory research applications via different pathways Combination research: emerging area with mechanistic rationale but limited published data BLL Peptides supplies both BPC-157 and TB-500 for laboratory research use

Regazzetti C, Bost F, Le Marchand-Brustel Y, Tanti J-F, Giorgetti-Peraldi S

Reports across the 1980s described DSIP modulation of responses to morphine, amphetamine and barbiturates in rodents, with a profile generally interpreted as opioid-system modulation rather than direct opioid-receptor binding (Graf & Kastin, 1984)

There is no long-term human safety data